Henry Ford Health System (HFHS) is the only hospital in Michigan participating in Phase 3 human clinical trials for Moderna’s mRNA-1273 Coronavirus Efficacy (COVE) vaccine study. Dr. Allison Weinmann, an infectious disease specialist at HFHS working on the trial, will share insight on vaccine development and the study enrollment process. Dr. Weinmann will also provide an update on Michigan’s current COVID-19 status during the Town Hall.
Dr. Weinmann will engage in a one-on-one discussion with Sandy K. Baruah, president and CEO of the Detroit Regional Chamber.
Related Posts
